Oct 05, 2017 12:01 pm UTC| Business
-- Presentations emphasize potential role for plazomicin in treating bloodstream infections (BSI) due to carbapenem-resistant Enterobacteriaceae (CRE) as well as potential long-term clinical benefits for patients with...
Oct 05, 2017 12:01 pm UTC| Business
BRANFORD, Conn., Oct. 05, 2017 -- BioXcel Therapeutics, a biopharmaceutical company committed to developing novel drugs targeting immuno-oncology and neurological and psychiatric diseases, today announced the...
Oct 05, 2017 12:01 pm UTC| Business
VANCOUVER, British Columbia, Oct. 05, 2017 -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) - (CSE:RQB) is pleased to announce the appointment of Mr. Dwight "Bill" Robinson. Mr. Robinson will lead RQB efforts...
dynaCERT Announces Proprietary Greenhouse Gas Tracking System
Oct 05, 2017 12:01 pm UTC| Business
TORONTO, Oct. 05, 2017 -- dynaCERT Inc. (TSX VENTURE:DYA) (OTCQB:DYFSF) ("dynaCERT" or the "Company") is pleased to announce that it has successfully filed a Provisional Patent Application in the United States for the...
SpotX Integrates with Amazon’s Transparent Ad Marketplace
Oct 05, 2017 12:01 pm UTC| Business
DENVER, Oct. 05, 2017 -- Video ad serving platform, SpotX, today announced the integration of its header bidding suite with Amazon Publisher Services’ Transparent Ad Marketplace (TAM). The SpotX and TAM integration is...
Oct 05, 2017 12:01 pm UTC| Business
SAN DIEGO, Oct. 05, 2017 -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based clinical-stage company translating best-in-class gene therapy technologies into lifesaving cell therapies, today presented preclinical...
Oct 05, 2017 12:01 pm UTC| Business
- Phase 3 pivotal trials enrolled a total of 1,503 patients- Topline efficacy and safety results expected in first quarter of 2018 MENLO PARK, Calif., Oct. 05, 2017 -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical...